| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | |
| Div Cover | n/a | |
| Op Mrgn | 29.4% | |
| ROCE | 33.6% |
| Latest | F'cast | |
|---|---|---|
| P/E | 16.3 | |
| PEG | 0.0 | |
| Pr/Revenue | 4.1 | |
| Pr/Book | 4.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 21.2% | |
| PBT | 425.7% | |
| EPS | 4018.8% | |
| DPS | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
| 31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
| 31-Dec-24 | 4,241.22 | 316.63 | 16.00¢ | 431.7 | n/a | -94% | n/a | 0.0% |
| 31-Dec-25 | 5,141.24 | 1,664.45 | 659.00¢ | 15.0 | 0.0 | +4,019% | n/a | 0.0% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 5,626.37 | 1,885.31 | 775.88¢ | 15.0 | 0.8 | +18% | n/a | 0.0% |
| 31-Dec-27 | 6,171.44 | 2,292.08 | 896.63¢ | 13.0 | 0.8 | +16% | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 116.71 |
| Change Today | $ -1.81 |
| % Change | -1.53 % |
| 52 Week High | $118.93 |
| 52 Week Low | $67.38 |
| Volume | 1,643,980 |
| Shares Issued | 198.46m |
| Market Cap | $23,162m |
| Beta | 0.05 |
| RiskGrade | 196 |
| Strong Buy | 6 |
| Buy | 5 |
| Neutral | 12 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 24 |

| Time | Volume / Share Price |
| 15:59 | 176 @ $116.75 |
| 15:59 | 100 @ $116.74 |
| 15:59 | 119 @ $116.75 |
| 15:59 | 100 @ $116.76 |
| 15:59 | 100 @ $116.77 |
You are here: research